Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: From the genetic, epigenetic, and tissue modeling perspectives

Stem Cell Research and Therapy

Volumn 4, Issue 4, 2013, Pages

  Chow, Maggie Zi ^a   Boheler, Kenneth R ^a,b   Li, Ronald A ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac differentiation; Cardiomyocyte; Chromatin remodeling; Epigenetic regulations; Histone modification; Human embryonic stem cell; Induced pluripotent stem cell; Regenerative medicine

Indexed keywords

ACTION POTENTIAL; BIOENGINEERING; CARDIOTOXICITY; CELL DIFFERENTIATION; CELL MATURATION; CELL THERAPY; CHROMATIN ASSEMBLY AND DISASSEMBLY; DISEASE MODEL; DNA METHYLATION; EMBRYONIC STEM CELL; EPIGENETICS; GENETIC MANIPULATION; GENETIC REGULATION; HEART FAILURE; HEART MUSCLE CELL; HIGH THROUGHPUT SCREENING; HUMAN; LONG QT SYNDROME 3; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATION; REGENERATIVE MEDICINE; REVIEW; TISSUE ENGINEERING; CYTOLOGY; DRUG DEVELOPMENT; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; METABOLISM; PROCEDURES;

CELL DIFFERENTIATION; DRUG DISCOVERY; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; MYOCYTES, CARDIAC; REGENERATION; TISSUE ENGINEERING;

EID: 84887940374     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt308     Document Type: Review

References (120)

1. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007 131 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
2. Induced pluripotent stem cell lines derived from human somatic cells. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA, Science 2007 318 1917 1920 10.1126/science.1151526 18029452
3. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Takahashi K, Yamanaka S, Cell 2006 126 663 676 10.1016/j.cell.2006.07.024 16904174 (Pubitemid 44233629)
4. A fresh look at iPS cells. Yamanaka S, Cell 2009 137 13 17 10.1016/j.cell.2009.03.034 19345179
5. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilic J, Pekarik V, Tiscornia G, Edel M, Boué S, Izpisúa Belmonte JC, Nat Biotechnol 2008 26 1276 1284 10.1038/nbt.1503 18931654
6. Reprogramming of T cells from human peripheral blood. Loh YH, Hartung O, Li H, Guo C, Sahalie JM, Manos PD, Urbach A, Heffner GC, Grskovic M, Vigneault F, Lensch MW, Park IH, Agarwal S, Church GM, Collins JJ, Irion S, Daley GQ, Cell Stem Cell 2010 7 15 19 10.1016/j.stem.2010.06.004 20621044
7. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, Sommer CA, Mostoslavsky G, Jaenisch R, Cell Stem Cell 2010 7 20 24 10.1016/j.stem.2010.06.002 20621045
8. Generation of induced pluripotent stem cells from human blood. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, Daley GQ, Blood 2009 113 5476 5479 10.1182/blood-2009-02-204800 19299331
9. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, Jia F, Hu S, Cherry AM, Robbins RC, Longaker MT, Wu JC, Proc Natl Acad Sci U S A 2009 106 15720 15725 10.1073/pnas.0908450106 19805220
10. Generation of induced pluripotent stem cells from urine. Zhou T, Benda C, Duzinger S, Huang Y, Li X, Li Y, Guo X, Cao G, Chen S, Hao L, Chan YC, Ng KM, Ho JC, Wieser M, Wu J, Redl H, Tse HF, Grillari J, Grillari-Voglauer R, Pei D, Esteban MA, J Am Soc Nephrol 2011 22 1221 1228 10.1681/ASN.2011010106 21636641
11. Generation and characterization of human cryptorchid-specific induced pluripotent stem cells from urine. Zhou J, Wang X, Zhang S, Gu Y, Yu L, Wu J, Gao T, Chen F, Stem Cells Dev 2013 22 717 725 10.1089/scd.2012.0260 23025704
12. Generation of human induced pluripotent stem cells from oral mucosa. Miyoshi K, Tsuji D, Kudoh K, Satomura K, Muto T, Itoh K, Noma T, J Biosci Bioeng 2010 110 345 350 10.1016/j.jbiosc.2010.03.004 20547351
13. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S, Nat Biotechnol 2008 26 101 106 10.1038/nbt1374 18059259
14. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Muhlestein W, Melton DA, Nat Biotechnol 2008 26 1269 1275 10.1038/nbt.1502 18849973
15. Human induced pluripotent stem cells free of vector and transgene sequences. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA, Science 2009 324 797 801 10.1126/science.1172482 19325077
16. A nonviral minicircle vector for deriving human iPS cells. Jia F, Wilson KD, Sun N, Gupta DM, Huang M, Li Z, Panetta NJ, Chen ZY, Robbins RC, Kay MA, Longaker MT, Wu JC, Nat Methods 2010 7 197 199 10.1038/nmeth.1426 20139967
17. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, Kim KS, Cell Stem Cell 2009 4 472 476 10.1016/j.stem.2009.05.005 19481515
18. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ, Cell Stem Cell 2010 7 618 630 10.1016/j.stem.2010.08.012 20888316
19. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, Takada N, Inoue M, Hasegawa M, Kawamata S, Nishikawa S, Proc Natl Acad Sci U S A 2011 108 14234 14239 10.1073/pnas.1103509108 21821793
20. Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins? Narsinh KH, Plews J, Wu JC, Mol Ther 2011 19 635 638 10.1038/mt.2011.41 21455209
21. Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. Narsinh KH, Sun N, Sanchez-Freire V, Lee AS, Almeida P, Hu S, Jan T, Wilson KD, Leong D, Rosenberg J, Yao M, Robbins RC, Wu JC, J Clin Invest 2011 121 1217 1221 10.1172/JCI44635 21317531
22. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, Wu JC, PLoS One 2010 5 8975 10.1371/journal.pone.0008975 20126639
23. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Bar-Nur O, Russ HA, Efrat S, Benvenisty N, Cell Stem Cell 2011 9 17 23 10.1016/j.stem.2011.06.007 21726830
24. Epigenetic memory in induced pluripotent stem cells. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ, Nature 2010 467 285 290 10.1038/nature09342 20644535
25. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, Ziller M, Croft GF, Amoroso MW, Oakley DH, Gnirke A, Eggan K, Meissner A, Cell 2011 144 439 452 10.1016/j.cell.2010.12.032 21295703
26. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, Chung Y, Honig GR, Kim KS, Lanza R, Stem Cells 2010 28 704 712 10.1002/stem.321 20155819
27. Epigenetic modulations of induced pluripotent stem cells: novel therapies and disease models. Huang C, Wu JC, Drug Discov Today Dis Models 2012 9 153 e160 10.1016/j.ddmod.2012.02.004 23646061
28. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, Gepstein L, J Clin Invest 2001 108 407 414 11489934 (Pubitemid 32730787)
29. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Xu C, Police S, Rao N, Carpenter MK, Circ Res 2002 91 501 508 10.1161/01.RES.0000035254.80718.91 12242268
30. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ, Circ Res 2003 93 32 39 10.1161/01.RES.0000080317.92718.99 12791707 (Pubitemid 36859038)
31. Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Yoon BS, Yoo SJ, Lee JE, You S, Lee HT, Yoon HS, Differentiation 2006 74 149 159 10.1111/j.1432-0436.2006.00063.x 16683985
32. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Niebruegge S, Bauwens CL, Peerani R, Thavandiran N, Masse S, Sevaptisidis E, Nanthakumar K, Woodhouse K, Husain M, Kumacheva E, Zandstra PW, Biotechnol Bioeng 2009 102 493 507 10.1002/bit.22065 18767184
33. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Mummery C, Ward-van Oostwaard D, Doevendans P, Spijker R, van den Brink S, Hassink R, van der Heyden M, Opthof T, Pera M, de la Riviere AB, Passier R, Tertoolen L, Circulation 2003 107 2733 2740 10.1161/01.CIR.0000068356.38592.68 12742992 (Pubitemid 36667249)
34. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE, Nat Biotechnol 2007 25 1015 1024 10.1038/nbt1327 17721512 (Pubitemid 47517637)
35. Human cardiovascular progenitor cells develop from a KDR§ssup§ +§esup§ embryonic-stem-cell-derived population. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, Henckaerts E, Bonham K, Abbott GW, Linden RM, Field LJ, Keller GM, Nature 2008 453 524 528 10.1038/nature06894 18432194 (Pubitemid 351733312)
36. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A, Ellis J, Keller G, Cell Stem Cell 2011 8 228 240 10.1016/j.stem.2010.12.008 21295278
37. Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Zhang J, Klos M, Wilson GF, Herman AM, Lian X, Raval KK, Barron MR, Hou L, Soerens AG, Yu J, Palecek SP, Lyons GE, Thomson JA, Herron TJ, Jalife J, Kamp TJ, Circ Res 2012 111 1125 1136 10.1161/CIRCRESAHA.112.273144 22912385
38. The future of induced pluripotent stem cells for cardiac therapy and drug development. Thorrez L, Sampaolesi M, Curr Pharm Des 2011 17 3258 3270 10.2174/138161211797904154 21919876
39. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Mummery CL, Zhang J, Ng ES, Elliott DA, Elefanty AG, Kamp TJ, Circ Res 2012 111 344 358 10.1161/CIRCRESAHA. 110.227512 22821908
40. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM, Raval KK, Zhang J, Kamp TJ, Palecek SP, Proc Natl Acad Sci U S A 2012 109 1848 E1857 10.1073/pnas.1200250109 22645348
41. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Graichen R, Xu X, Braam SR, Balakrishnan T, Norfiza S, Sieh S, Soo SY, Tham SC, Mummery C, Colman A, Zweigerdt R, Davidson BP, Differentiation 2008 76 357 370 10.1111/j.1432-0436.2007.00236.x 18021257 (Pubitemid 351522761)
42. Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state. Moore JC, Fu J, Chan YC, Lin D, Tran H, Tse HF, Li RA, Biochem Biophys Res Commun 2008 372 553 558 10.1016/j.bbrc.2008.05.076 18503758
43. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Xue T, Cho HC, Akar FG, Tsang SY, Jones SP, Marban E, Tomaselli GF, Li RA, Circulation 2005 111 11 20 10.1161/01.CIR.0000151313.18547.A2 15611367 (Pubitemid 40070838)
44. Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. Dick E, Rajamohan D, Ronksley J, Denning C, Biochem Soc Trans 2010 38 1037 1045 10.1042/BST0381037 20659000
45. Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to beta-adrenergic stimulation. Novak A, Barad L, Zeevi-Levin N, Shick R, Shtrichman R, Lorber A, Itskovitz-Eldor J, Binah O, J Cell Mol Med 2012 16 468 482 10.1111/j.1582-4934.2011.01476.x 22050625
46. Absence of transverse tubules contributes to non-uniform Ca§ssup§2+§esup§ wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes. Lieu DK, Liu J, Siu CW, McNerney GP, Tse HF, Abu-Khalil A, Huser T, Li RA, Stem Cells Dev 2009 18 1493 1500 10.1089/scd.2009.0052 19290776
47. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Elliott DA, Braam SR, Koutsis K, Ng ES, Jenny R, Lagerqvist EL, Biben C, Hatzistavrou T, Hirst CE, Yu QC, Skelton RJ, Ward-van Oostwaard D, Lim SM, Khammy O, Li X, Hawes SM, Davis RP, Goulburn AL, Passier R, Prall OW, Haynes JM, Pouton CW, Kaye DM, Mummery CL, Elefanty AG, Stanley EG, Nat Methods 2011 8 1037 1040 10.1038/nmeth.1740 22020065
48. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Dubois NC, Craft AM, Sharma P, Elliott DA, Stanley EG, Elefanty AG, Gramolini A, Keller G, Nat Biotechnol 2011 29 1011 1018 10.1038/nbt.2005 22020386
49. Prospective isolation of human embryonic stem cell-derived cardiovascular progenitors that integrate into human fetal heart tissue. Ardehali R, Ali SR, Inlay MA, Abilez OJ, Chen MQ, Blauwkamp TA, Yazawa M, Gong Y, Nusse R, Drukker M, Weissman IL, Proc Natl Acad Sci U S A 2013 110 3405 3410 10.1073/pnas. 1220832110 23391730
50. Epigenetic regulation of the electrophysiological phenotype of human embryonic stem cell-derived ventricular cardiomyocytes: insights for driven maturation and hypertrophic growth. Chow MZ, Geng L, Kong CW, Keung W, Fung JC, Boheler K, Li RA, Stem Cells Dev 2013 Epub ahead of print
51. Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Lieu DK, Fu JD, Chiamvimonvat N, Tung KC, McNerney GP, Huser T, Keller G, Kong CW, Li RA, Circ Arrhythm Electrophysiol 2013 6 191 201 10.1161/CIRCEP.111.973420 23392582
52. Overexpression of Kir2.1 channel in embryonic stem cell-derived cardiomyocytes attenuates posttransplantation proarrhythmic risk in myocardial infarction. Liao SY, Tse HF, Chan YC, Mei-Chu Yip P, Zhang Y, Liu Y, Li RA, Hear Rhythm 2013 10 273 282 10.1016/j.hrthm.2012.10.008
53. An inducible transgene expression system for regulated phenotypic modification of human embryonic stem cells. Fu JD, Jung Y, Chan CW, Li RA, Stem Cells Dev 2008 17 315 324 10.1089/scd.2007.0114 18447646 (Pubitemid 351630172)
54. Facilitated maturation of Ca§ssup§2+§esup§ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression. Liu J, Lieu DK, Siu CW, Fu JD, Tse HF, Li RA, Am J Physiol Cell Physiol 2009 297 152 C159 10.1152/ajpcell.00060.2009 19357236
55. Human ESC/iPSC-based 'omics' and bioinformatics for translational research. Müller GA, Tarasov KV, Gundry RL, Boheler KR, Drug Discov Today Dis Models 2012 9 161 e170 23682293
56. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES, Cell 2006 125 315 326 10.1016/j.cell.2006.02.041 16630819
57. Distinct contributions of histone H3 lysine 9 and 27 methylation to locus-specific stability of polycomb complexes. Ringrose L, Ehret H, Paro R, Mol Cell 2004 16 641 653 10.1016/j.molcel.2004.10.015 15546623 (Pubitemid 39531886)
58. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, Serrano M, Blasco MA, Cell Stem Cell 2009 4 141 154 10.1016/j.stem.2008.12.010 19200803
59. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Mali P, Chou BK, Yen J, Ye Z, Zou J, Dowey S, Brodsky RA, Ohm JE, Yu W, Baylin SB, Yusa K, Bradley A, Meyers DJ, Mukherjee C, Cole PA, Cheng L, Stem Cells 2010 28 713 720 10.1002/stem.402 20201064
60. Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature. Xu H, Yi BA, Wu H, Bock C, Gu H, Lui KO, Park JH, Shao Y, Riley AK, Domian IJ, Hu E, Willette R, Lepore J, Meissner A, Wang Z, Chien KR, Cell Res 2012 22 142 154 10.1038/cr.2011.171 22064699
61. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D, Cell 2010 142 375 386 10.1016/j.cell.2010.07.002 20691899
62. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D, Nature 2012 485 593 598 10.1038/nature11044 22522929
63. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Takeuchi JK, Bruneau BG, Nature 2009 459 708 711 10.1038/nature08039 19396158
64. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Chen JX, Krane M, Deutsch MA, Wang L, Rav-Acha M, Gregoire S, Engels MC, Rajarajan K, Karra R, Abel ED, Wu JC, Milan D, Wu SM, Circ Res 2012 111 50 55 10.1161/CIRCRESAHA.112.270264 22581928
65. Acetylation of GATA-4 is involved in the differentiation of embryonic stem cells into cardiac myocytes. Kawamura T, Ono K, Morimoto T, Wada H, Hirai M, Hidaka K, Morisaki T, Heike T, Nakahata T, Kita T, Hasegawa K, J Biol Chem 2005 280 19682 19688 10.1074/jbc.M412428200 15764815 (Pubitemid 41379492)
66. Epigenetic mechanisms in cardiac development and disease. Vallaster M, Vallaster CD, Wu SM, Acta Biochim Biophys Sin 2012 44 92 102 10.1093/abbs/gmr090 22194017
67. Epigenetic factors and cardiac development. van Weerd JH, Koshiba-Takeuchi K, Kwon C, Takeuchi JK, Cardiovasc Res 2011 91 203 211 10.1093/cvr/cvr138 21606181
68. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM, Nature 2005 433 769 773 10.1038/nature03315 15685193 (Pubitemid 40292988)
69. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R, Nat Genet 2007 39 380 385 10.1038/ng1969 17259983 (Pubitemid 46328490)
70. Dicer is essential for mouse development. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, Mills AA, Elledge SJ, Anderson KV, Hannon GJ, Nat Genet 2003 35 215 217 10.1038/ng1253 14528307 (Pubitemid 37363172)
71. Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Wilson KD, Hu S, Venkatasubrahmanyam S, Fu JD, Sun N, Abilez OJ, Baugh JJ, Jia F, Ghosh Z, Li RA, Butte AJ, Wu JC, Circ Cardiovasc Genet 2010 3 426 435 10.1161/CIRCGENETICS.109. 934281 20733065
72. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, Doevendans PA, Goumans MJ, Arterioscler Thromb Vasc Biol 2010 30 859 868 10.1161/ATVBAHA.109.197434 20081117
73. Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. Fu JD, Rushing SN, Lieu DK, Chan CW, Kong CW, Geng L, Wilson KD, Chiamvimonvat N, Boheler KR, Wu JC, Keller G, Hajjar RJ, Li RA, PLoS One 2011 6 27417 10.1371/journal.pone.0027417 22110643
74. MicroRNAs as regulators of differentiation and cell fate decisions. Ivey KN, Srivastava D, Cell Stem Cell 2010 7 36 41 10.1016/j.stem.2010.06.012 20621048
75. Control of stress-dependent cardiac growth and gene expression by a microRNA. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN, Science 2007 316 575 579 10.1126/science.1139089 17379774 (Pubitemid 46683138)
76. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Jayawardena TM, Egemnazarov B, Finch EA, Zhang L, Payne JA, Pandya K, Zhang Z, Rosenberg P, Mirotsou M, Dzau VJ, Circ Res 2012 110 1465 1473 10.1161/CIRCRESAHA.112.269035 22539765
77. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Wamstad JA, Alexander JM, Truty RM, Shrikumar A, Li F, Eilertson KE, Ding H, Wylie JN, Pico AR, Capra JA, Erwin G, Kattman SJ, Keller GM, Srivastava D, Levine SS, Pollard KS, Holloway AK, Boyer LA, Bruneau BG, Cell 2012 151 206 220 10.1016/j.cell.2012.07.035 22981692
78. A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Paige SL, Thomas S, Stoick-Cooper CL, Wang H, Maves L, Sandstrom R, Pabon L, Reinecke H, Pratt G, Keller G, Moon RT, Stamatoyannopoulos J, Murry CE, Cell 2012 151 221 232 10.1016/j.cell.2012.08.027 22981225
79. Epigenomics of human embryonic stem cells and induced pluripotent stem cells: insights into pluripotency and implications for disease. Rada-Iglesias A, Wysocka J, Genome Med 2011 3 36 10.1186/gm252 21658297
80. Cells snag top modelling job. Callaway E, Nature 2011 469 279 10.1038/469279a 21248811
81. Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications. Vidarsson H, Hyllner J, Sartipy P, Stem Cell Rev 2010 6 108 120 10.1007/s12015-010-9113-x 20091143
82. Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective. Poon E, Kong CW, Li RA, Mol Pharm 2011 8 1495 1504 10.1021/mp2002363 21879736
83. Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models. Kong CW, Akar FG, Li RA, Thromb Haemost 2010 104 30 38 10.1160/TH10-03-0189 20539906
84. Induced pluripotent stem cells as a disease model for studying inherited arrhythmias: promises and hurdles. Lui KO, Stachel MW, Lieu DK, Li RA, Bu L, Drug Discov Today Dis Models 2012 9 199 e207 10.1016/j.ddmod.2012.09.001
85. Cardiomyocyte differentiation of human induced pluripotent stem cells. Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park IH, Gepstein L, Circulation 2009 120 1513 1523 10.1161/CIRCULATIONAHA.109.868885 19786631
86. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang YS, Schaniel C, Lee DF, Yang L, Kaplan AD, Adler ED, Rozov R, Ge Y, Cohen N, Edelmann LJ, Chang B, Waghray A, Su J, Pardo S, Lichtenbelt KD, Tartaglia M, Gelb BD, Lemischka IR, Nature 2010 465 808 812 10.1038/nature09005 20535210
87. Modelling the long QT syndrome with induced pluripotent stem cells. Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel G, Hammerman H, Boulos M, Gepstein L, Nature 2011 471 225 229 10.1038/nature09747 21240260
88. An electrifying iPSC disease model: long QT syndrome type 2 and heart cells in a dish. Kamp TJ, Cell Stem Cell 2011 8 130 131 10.1016/j.stem.2011.01. 010 21295269
89. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flugel L, Dorn T, Goedel A, Hohnke C, Hofmann F, Seyfarth M, Sinnecker D, Schomig A, Laugwitz KL, N Engl J Med 2010 363 1397 1409 10.1056/NEJMoa0908679 20660394
90. Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias. Hoekstra M, Mummery CL, Wilde AA, Bezzina CR, Verkerk AO, Front Physiol 2012 3 346 23015789
91. Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. Kim C, Majdi M, Xia P, Wei KA, Talantova M, Spiering S, Nelson B, Mercola M, Chen HS, Stem Cells Dev 2010 19 783 795 10.1089/scd.2009.0349 20001453
92. Engineered human pluripotent stem cell-derived cardiac cells and tissues for electrophysiological studies. Lieu DK, Turnbull IC, Costa KD, Li RA, Drug Discov Today Dis Models 2012 9 209 e217 10.1016/j.ddmod.2012.06.002
93. Cardiac tissue engineering using human stem cell-derived cardiomyocytes for disease modeling and drug discovery. Turnbull IC, Lieu DK, Li RA, Costa KD, Drug Discov Today Dis Models 2012 9 219 e227
94. Development of a drug screening platform based on engineered heart tissue. Hansen A, Eder A, Bonstrup M, Flato M, Mewe M, Schaaf S, Aksehirlioglu B, Schwoerer AP, Uebeler J, Eschenhagen T, Circ Res 2010 107 35 44 10.1161/CIRCRESAHA.109.211458 20448218
95. Engineered cardiac tissues for in vitro assessment of contractile function and repair mechanisms. Kim do E, Lee EJ, Martens TP, Kara R, Chaudhry HW, Itescu S, Costa KD, Conf Proc IEEE Eng Med Biol Soc 2006 1 849 852 17946863 (Pubitemid 46519996)
96. Engineered cardiac organoid chambers: toward a functional biological model ventricle. Lee EJ, Kim Do E, Azeloglu EU, Costa KD, Tissue Eng Part A 2008 14 215 225 10.1089/tea.2007.0351 18333774
97. Multiscale biomimetic topography for the alignment of neonatal and embryonic stem cell-derived heart cells. Luna JI, Ciriza J, Garcia-Ojeda ME, Kong M, Herren A, Lieu DK, Li RA, Fowlkes CC, Khine M, McCloskey KE, Tissue Eng Part C Methods 2011 17 579 588 10.1089/ten.tec.2010.0410 21235325
98. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Caspi O, Lesman A, Basevitch Y, Gepstein A, Arbel G, Habib IH, Gepstein L, Levenberg S, Circ Res 2007 100 263 272 10.1161/01.RES.0000257776. 05673.ff 17218605 (Pubitemid 46208727)
99. Immunosuppression by embryonic stem cells. Koch CA, Geraldes P, Platt JL, Stem Cells 2008 26 89 98 10.1634/stemcells.2007-0151 17962705
100. In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. Swijnenburg RJ, Schrepfer S, Cao F, Pearl JI, Xie X, Connolly AJ, Robbins RC, Wu JC, Stem Cells Dev 2008 17 1023 1029 10.1089/scd.2008.0091 18491958
101. Immunogenicity of induced pluripotent stem cells. Zhao T, Zhang ZN, Rong Z, Xu Y, Nature 2011 474 212 215 10.1038/nature10135 21572395
102. Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Mullally A, Ritz J, Blood 2007 109 1355 1362 10.1182/blood-2006-06-030858 17008540 (Pubitemid 46239565)
103. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Araki R, Uda M, Hoki Y, Sunayama M, Nakamura M, Ando S, Sugiura M, Ideno H, Shimada A, Nifuji A, Abe M, Nature 2013 494 100 104 10.1038/nature11807 23302801
104. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Yoshida Y, Yamanaka S, Circulation 2010 122 80 87 10.1161/CIRCULATIONAHA.109.881433 20606130
105. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, Yankelson L, Aronson D, Beyar R, Gepstein L, J Am Coll Cardiol 2007 50 1884 1893 10.1016/j.jacc.2007.07.054 17980256 (Pubitemid 350007960)
106. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. van Laake LW, Passier R, Monshouwer-Kloots J, Verkleij AJ, Lips DJ, Freund C, den Ouden K, Ward-van Oostwaard D, Korving J, Tertoolen LG, van Echteld CJ, Doevendans PA, Mummery CL, Stem Cell Res 2007 1 9 24 10.1016/j.scr.2007.06.001 19383383 (Pubitemid 350251944)
107. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. van Laake LW, Passier R, Doevendans PA, Mummery CL, Circ Res 2008 102 1008 1010 10.1161/CIRCRESAHA.108.175505 18436793 (Pubitemid 351667854)
108. Human embryonic stem cell transplantation to repair the infarcted myocardium. Leor J, Gerecht S, Cohen S, Miller L, Holbova R, Ziskind A, Shachar M, Feinberg MS, Guetta E, Itskovitz-Eldor J, Heart 2007 93 1278 1284 10.1136/hrt.2006.093161 17566061 (Pubitemid 47492921)
109. Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury. Kofidis T, Lebl DR, Swijnenburg RJ, Greeve JM, Klima U, Robbins RC, Eur J Cardiothorac Surg 2006 29 50 55 10.1016/j.ejcts.2005. 10.015 16337396 (Pubitemid 41831348)
110. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. Fernandes S, Naumova AV, Zhu WZ, Laflamme MA, Gold J, Murry CE, J Mol Cell Cardiol 2010 49 941 949 10.1016/j.yjmcc.2010.09.008 20854826
111. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, Huber I, Satin J, Itskovitz-Eldor J, Gepstein L, Nat Biotechnol 2004 22 1282 1289 10.1038/nbt1014 15448703 (Pubitemid 39341201)
112. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, Kim J, Palpant NJ, Gantz J, Moyes KW, Reinecke H, Van Biber B, Dardas T, Mignone JL, Izawa A, Hanna R, Viswanathan M, Gold JD, Kotlikoff MI, Sarvazyan N, Kay MW, Murry CE, Laflamme MA, Nature 2012 489 322 325 10.1038/nature11317 22864415
113. Human pluripotent stem cell-derived cardiovascular progenitors for heart regeneration. Lui KO, Stachel MW, Li RA, Bu L, Drug Discov Today Dis Models 2012 9 189 e197 10.1016/j.ddmod.2012.08.003
114. Cardiac regeneration using human embryonic stem cells: producing cells for future therapy. Wong SS, Bernstein HS, Regen Med 2010 5 763 775 10.2217/rme.10.52 20868331
115. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. Moretti A, Bellin M, Jung CB, Thies TM, Takashima Y, Bernshausen A, Schiemann M, Fischer S, Moosmang S, Smith AG, Lam JT, Laugwitz KL, FASEB J 2010 24 700 711 10.1096/fj.09-139477 19850773
116. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B, Bellamy V, Rucker-Martin C, Barbry P, Bel A, Bruneval P, Cowan C, Pouly J, Mitalipov S, Gouadon E, Binder P, Hagege A, Desnos M, Renaud JF, Menasche P, Puceat M, J Clin Invest 2010 120 1125 1139 10.1172/JCI40120 20335662
117. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Urbanek K, Torella D, Sheikh F, De Angelis A, Nurzynska D, Silvestri F, Beltrami CA, Bussani R, Beltrami AP, Quaini F, Bolli R, Leri A, Kajstura J, Anversa P, Proc Natl Acad Sci U S A 2005 102 8692 8697 10.1073/pnas.0500169102 15932947 (Pubitemid 40862797)
118. Isolation and expansion of adult cardiac stem cells from human and murine heart. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, Salio M, Battaglia M, Latronico MV, Coletta M, Vivarelli E, Frati L, Cossu G, Giacomello A, Circ Res 2004 95 911 921 10.1161/01.RES.0000147315.71699.51 15472116 (Pubitemid 39435006)
119. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Smith RR, Barile L, Cho HC, Leppo
120. Adult cardiac progenitor cell aggregates exhibit survival benefit both in vitro and in vivo. Bauer M, Kang L, Qiu Y, Wu J, Peng M, Chen HH, Camci-Unal G, Bayomy AF, Sosnovik DE, Khademhosseini A, Liao R, PLoS One 2012 7 50491 10.1371/journal.pone.0050491 23226295